These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 2678934

  • 21. Evaluation of chemotherapy with magnetic resonance imaging in patients with regionally metastatic or unresectable bladder cancer.
    Schrier BP, Peters M, Barentsz JO, Witjes JA.
    Eur Urol; 2006 Apr; 49(4):698-703. PubMed ID: 16464531
    [Abstract] [Full Text] [Related]

  • 22. Combined intravenous and intra-arterial cyclophosphamide, doxorubicin, and cisplatin (CISCA) in the management of select patients with invasive urothelial tumors.
    Logothetis CJ, Samuels ML, Selig DE, Wallace S, Johnson DE.
    Cancer Treat Rep; 1985 Jan; 69(1):33-8. PubMed ID: 2981619
    [Abstract] [Full Text] [Related]

  • 23. [Combination chemotherapy of 5-fluorouracil (5-FU), adriamycin (ADM), cis-diamminedichloroplatinum (II) (CDDP) and mitomycin C (MMC) (FAP.MMC) in advanced gastric cancer].
    Ozeki H, Ogawa M, Horikoshi N, Inoue K, Mukaiyama T, Nagamine D, Ito Y, Imajo K, Shinagawa K.
    Gan To Kagaku Ryoho; 1988 Jan; 15(1):91-5. PubMed ID: 3122669
    [Abstract] [Full Text] [Related]

  • 24. [[Neoadjuvant chemotherapy (cisplatin, doxorubicin, cyclophosphamide) in the treatment of invasive urothelial tumors of the bladder. Preliminary results of a prospective study concerning 22 patients].
    Trifard F, Chrétien Y, Vallantin X, Collet C, Lachand AT, Dufour B.
    Ann Urol (Paris); 1988 Jan; 22(3):216-9. PubMed ID: 3401004
    [Abstract] [Full Text] [Related]

  • 25. [Evaluation of chemotherapy in advanced urothelial carcinoma: with special reference to combination chemotherapy with adriamycin, cyclophosphamide and cisplatin (ACE chemotherapy)].
    Tobisu K, Matsumoto K, Takai K, Kakizoe T.
    Nihon Hinyokika Gakkai Zasshi; 1987 Feb; 78(2):327-34. PubMed ID: 3613336
    [No Abstract] [Full Text] [Related]

  • 26. Pre-cystectomy chemotherapy with sequentially administered cisplatin, cyclophosphamide and adriamycin in invasive transitional cell carcinoma of the bladder (preliminary report).
    Guazzieri S, Sperandio P, Fandella A, Garbeglio A, Pegoraro V, Chiarion V, Fiorentino M, Pagano F.
    Prog Clin Biol Res; 1988 Feb; 260():599-602. PubMed ID: 3362909
    [No Abstract] [Full Text] [Related]

  • 27. [Chemotherapy of metastatic urothelial carcinoma].
    Kihara K, Sakuramoto T, Washizuka M, Kawai T, Ogawa M.
    Gan To Kagaku Ryoho; 1982 Nov; 9(11):2046-7. PubMed ID: 6892194
    [Abstract] [Full Text] [Related]

  • 28. [A study of the use of methotrexate, vincristine, cis-platinum, cyclophosphamide, adriamycin, bleomycin (MVP-CAB) in metastatic transitional cell carcinoma].
    Fujii A, Den S, Nakamura I, Ohshima H, Nagata H, Izumi T, Takechi Y, Kawaida T, Kamidono S, Yasuno H.
    Hinyokika Kiyo; 1987 May; 33(5):697-703. PubMed ID: 2444083
    [Abstract] [Full Text] [Related]

  • 29. [Chemotherapy of recurrent squamous cell carcinomas in the ENT area with cisplatin/adriamycin (DDP/ADM) and methotrexate/5-fluorouracil (MTX/5-Flu): a retrospective comparison of 2 protocols].
    Jakse R, Scherlacher A, Lehnert M, Haas J.
    HNO; 1986 Jun; 34(6):235-40. PubMed ID: 3744908
    [Abstract] [Full Text] [Related]

  • 30. A phase I/II trial of transurethral surgery combined with concurrent cisplatin, 5-fluorouracil and twice daily radiation followed by selective bladder preservation in operable patients with muscle invading bladder cancer.
    Zietman AL, Shipley WU, Kaufman DS, Zehr EM, Heney NM, Althausen AF, McGovern FJ.
    J Urol; 1998 Nov; 160(5):1673-7. PubMed ID: 9783929
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. M-VAC: methotrexate (MTX), vinblastine (VLB), adriamycin (ADM), and cisplatin (DDP) for metastatic and node positive carcinoma of the urothelium.
    Sternberg CN, Yagoda A, Scher HI, Whitmore WF, Herr HW, Morse MJ, Sogani PC, Watson RC, Hollander PS, Fair WR.
    Prog Clin Biol Res; 1988 Nov; 260():481-5. PubMed ID: 3283768
    [No Abstract] [Full Text] [Related]

  • 33. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G, Marschke R, Camoriano JK, Sorensen JM, Sloan JA, Richardson RL.
    Cancer J Sci Am; 1997 Nov; 3(5):297-302. PubMed ID: 9327154
    [Abstract] [Full Text] [Related]

  • 34. Impact of methotrexate, vinblastine, adriamycin, and cisplatin chemotherapy in patients with lymph node metastases from transitional cell carcinoma of the lower urinary tract.
    Koch MO, Coussens D.
    Semin Urol; 1993 Feb; 11(1):14-9. PubMed ID: 8465122
    [No Abstract] [Full Text] [Related]

  • 35. Angiotensin-II combined intra-arterial chemotherapy for locally advanced bladder cancer: a case series study at a single institution.
    Shimabukuro T, Nakamura K, Uchiyama K, Tei Y, Aoki A, Naito K.
    Hinyokika Kiyo; 2006 Feb; 52(2):99-105. PubMed ID: 16541762
    [Abstract] [Full Text] [Related]

  • 36. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer.
    Hitt R, López-Pousa A, Martínez-Trufero J, Escrig V, Carles J, Rizo A, Isla D, Vega ME, Martí JL, Lobo F, Pastor P, Valentí V, Belón J, Sánchez MA, Chaib C, Pallarés C, Antón A, Cervantes A, Paz-Ares L, Cortés-Funes H.
    J Clin Oncol; 2005 Dec 01; 23(34):8636-45. PubMed ID: 16275937
    [Abstract] [Full Text] [Related]

  • 37. Combination chemotherapy of cisplatin, methotrexate, vinblastine, and high-dose tamoxifen for transitional cell carcinoma.
    Hsu CH, Chen J, Wu CY, Cheng AL, Pu YS.
    Anticancer Res; 2001 Dec 01; 21(1B):711-5. PubMed ID: 11299831
    [Abstract] [Full Text] [Related]

  • 38. [Neoadjuvant chemoradiotherapy in locally invasive transitional cell carcinoma of the urinary bladder: early results of PVB and CAP therapy].
    Momose H, Arai K, Nakagawa Y, Fujimoto K, Tsujimoto S, Cho M, Tani Y, Saka M, Nakatsuji F, Iwai A.
    Hinyokika Kiyo; 1989 May 01; 35(5):781-8. PubMed ID: 2478001
    [Abstract] [Full Text] [Related]

  • 39. [Results of combination chemotherapy in advanced urothelial cancer].
    Komatsubara S, Watanabe M, Kitamura Y, Sakata Y.
    Hinyokika Kiyo; 1988 Oct 01; 34(10):1697-702. PubMed ID: 3245518
    [Abstract] [Full Text] [Related]

  • 40. [Effect of combination chemotherapy of tegafur, adriamycin and cisplatin on patients with advanced relapsing prostatic carcinoma and advanced bladder tumor].
    Yoshida K, Nakame Y, Horiuchi S, Kaneoya F, Kuroda T, Tanoiri A, Koizumi M, Takahashi M, Negishi T, Saitoh H.
    Gan To Kagaku Ryoho; 1986 Apr 01; 13(4 Pt 1):1083-5. PubMed ID: 3083786
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.